Tumour-associated cell-surface glycoprotein is associated with tumour progression in gastric cancer. We investigated the biological significance of tumour-associated cell-surface glycoprotein, determined by the binding of Helix pomatia agglutinin (HPA), with regrd to survival time and to the malignant potential of cancer cells in serosally invasive gastric cancer in 119 patients. HPA was positively stained in 75 of 119 patients (63.0%) with gastric cancer with serosal invasion. In patients with HPA-positive tissue, the tumour was larger than in HPA-negative cases and was frequently located in the middle third of the stomach. The incidence of lymph node metastasis was higher than in patients with HPA-negative tissue. There were no differences between the cases staining negatively and positively with HPA with respect to the other factors eained. Gastric cancer tissues with HPA-positive staining revealed a higher positive rate of abnormal p53 staining and a higher concentration of proliferating cell nuclear antigen (PCNA) labelling. The survival time of the patients with HPA positive staining was shorter than for those whose tissues were HPA negative. Thus, tumour-associated cell-surface glycoprotein is apparently closely related to the malignant potential of serosally invasive gastnc cancer.
Lectins are proteins of plant or animal origin which bind speifically to glycoconjugates. Using labelled lectin, carbohydrate residues in tissue sections can be detected using histochemical procedures. This has led to a search for lectin binding to detect carbohydrates related to tumour metastatic behaviour (Schumacher et al., 1992) , since cell-surface glycoproteins have important roles in cell-to-cell interaction, invasion and metastatic potential (Dennis et al., 1987; Buckley and Carlsen, 1988; Olden, 1993) . We have suggested that binding sites for a lectin from the Roman snail, Helix pomatia agglutinin (HPA), is a predictive marker of tumour progression in gastric cancer (Kakeji et al., 1991a) . HPA, with a molecular mass of 79 kDa and a strong affinity for N-acetyl-D-galactosamine and N-acetyl-i-glucosamine, specifically agglutinates human type A erythrocytes (Kawai et al., 1991) . In particular, the presence of lymph node metastasis is related to HPA binding of gastric cancer cells. The intracellular events linlked to these antigens expressed on the surface of gastric cancer cells have remained unresolved.
At the level of the nucleus, abnormalities of tumourrelated genes and growth potential have been reported to relate to the poor prognosis of the patient (Mori et al., 1993; Uchino et al., 1993) . The p53 gene is a tumour-suppressor gene and p53 is a nuclear protein, a transcriptional activator which regulates the onset of DNA replication at the GI-S boundary (Vogelstein et al., 1992) . The great majority of mutations in the p53 gene are missense in type, leading to production of full-length proteins with an altered conformation and abnormal biological properties (Hollstein et al., 1991) . Unlike the wild-type protein, which has a short halflife, the great majority of tetramers containing mutant protein are stable and therefore readily detectable by immunochemistry using antibodies reactive to p53 (KikuchiYanoshita et al., 1992 Cancer, 1981 Cancer, , 1993 Maehara et al., 1992 (Kakeji et al., 1993 (Table II) .
HPA staining and proliferating activity The proliferating activity, expressed by PCNA labelling, was significantly higher in tumour tissues with HPA-positive staining than in those with HPA-negative staining, with a significant difference (P<0.01) (Table III) .
Recurrence pattern
The rate of recurrence was 40.9% (18/44) for HPA-negative patients and 74.7% (56/75) for HPA-positive ones (Table   IV) . Peritoneal and local recurrences were mainly noted in HPA-negative patients, while there was a variety of forms of recurrences, including peritoneal and distant organ recurrences in the HPA-positive patients.
Survival rate
The overall survival curve is shown in Figure 1, Changes in cell-surface glycoproteins are thought to be associated with altered cell adhesion and with the development of invasive and metastatic properties in experimental and human tumours (Dennis et al., 1987; Buckley and Carlsen, 1988; Dennis and Laferte, 1989; SeUl, 1990) . Changes in cell-surface carbohydrate occur during tumour progression, and these changes can be detected by studying the binding patterns of lectins (Hiraizumi et al., 1990) . Positive staining for HPA, which recognises N-acetyl-D-galactosamnine and Nacetyl-E-glucosamine, was noted in cases of breast cancer to be associated with metastasis to local lymph nodes and with a higher recurrence and mortality rate (Fukutomi et al., 1989) . We have reported that the altered glycosylation of cell-surface glycoprotein in gastric cancer, which was recognised by HPA, is associated with lymph node metastasis and a higher mortality rate, and we suggested that HPA staining of the gastric cancer is closely related to the potential for lymphatic spread of gastric cancer (Kakeji et al., 1991a) . These data prompted us to determine the molecular events related to HPA-positive gastric cancers. A close relation between HPA staining and amplification of the c-myc gene or c-erbB-2 gene has been noted in human breast cancer tissues (Fukutomi et al., 1991; Thomas et al., 1993) . In the present study, we clarified the correlations between HPA staining of cancer cells, abnormality of the p53 gene and the prolferating activity determined by PCNA labelling in gastric cancer. Carder et al. (1993) stated that cells containing abnormal p53 protein are particularly at risk of endoreduplication and hence of tetraploidy. Failure to regulate p53 expression may lead to uncontrolled cell growth (Lane, 1992; Livingstone et al., 1992; Yin et al., 1992) . The concentrations of PCNA, a highly conserved 36 kDa acidic protein and auxiliary protein for DNA polymerase 6, which is directly involved in DNA synthesis (Hall et al., 1990; Waseem and Lane, 1990) , correlate with the proliferative state of cells and with the prognosis in gastric cancer (Mori et al., 1993) . PCNA labelling correlates with other parameters of cell proliferation (Ki-67 score, S-phase fraction, as determined by flow cytometry, bromodeoxyuridine and thymidine incorporations into DNA, and mitotic index) and with DNA ploidy in human tumours (Hall et al., 1990; Kakeji et al., 1991b) . Thus, intracellular events related to p53 abnormality and detected by p53 protein staining are linked to increased cellular proliferation and to the phenotype of altered cell membrane glycoproteins. We have reported that overexpression of p53 is closely related to the potential of cancer cells to metastasise to lymph nodes in gastric cancer (Kakeji et al., 1993 ). Joypaul et al. (1994 reported that p53 overexpression is an independent marker of a shorter survival for gastric cancer patients. The p53 abnormality is likely to accelerate the lymphatic spread of cancer cells through association with altered cell membrane glycoproteins and a poorer prognosis. The results of this study suggest that abnormalities in cell-surface glycoproteims are closely linked to an abnormal p53 gene and to a higher growth potential in gastric cancer. These prognostic factors are assumed to be related to the aggressiveness of gastric cancer. As tumours with high proliferative activity are sensitive to anti-cancer drugs (Maehara et al., 1990) , HPA staining may aid in designing treatment strategies for particular groups of patients.
